As shown in Figure 4E & 4F, patients with high DNMT1 expression in their breast cancer samples had lower relapse-free survival (RFS) and distance metastasis-free survival (DMFS) than those with low DNMT1 expression in the samples. This evidence concerns the gene DNMT1 and breast carcinoma.